Werewolf Therapeutics (HOWL)
(Delayed Data from NSDQ)
$6.02 USD
-0.22 (-3.53%)
Updated May 1, 2024 04:00 PM ET
After-Market: $6.01 -0.01 (-0.17%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth C Momentum F VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 29% (73 out of 251)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.00 | 1.35 | 9.99 |
Current Quarter Estimate | -0.35 | 7.43 | 60.00 |
Year Ago Quarter Estimate | -0.34 | 0.12 | 52.54 |
Next Quarter Estimate | -0.29 | 7.81 | 61.00 |
Next Year Estimate | -1.60 | 37.76 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -31.43 | 12.60 | 17.08 |
Next Year | -15.94 | 7.70 | 8.00 |
Last 5 Years | NA | 1.00 | 8.10 |
Next 5 Years | 3.90 | 20.10 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -2.18 |
Price/Book (MRQ) | 2.03 | 1.99 |
Price/Cash Flow (MRFY) | NA | 14.06 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -187.37% | 1.76% |
Return on Equity (TTM) | -32.25% | -12.43% |
Debt to Equity (MRQ) | NA | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.